secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2022-08-31T23:59:59+00:00
Accession:  0001493152-22-024444
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 3.02, 5.02, 8.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant Medical closes $6.75M first tranche of private placement; appoints Vizirgianakis Chairman
--------------------------------------------------------------------------------

- First tranche: sold 14.1M shares and warrants for 3.5M shares at ~$6.75M to accredited investors.
- Second tranche of ~$3.0M (6.2M shares + 1.6M warrants) expected early October 2022.
- Board expanded to 7 directors; Stavros Vizirgianakis elected Chairman, replacing Jeffrey Peters.
- 2022 Annual Meeting set for October 26, 2022; proxy materials to be mailed around September 20.
- Net proceeds to support working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000149315222024444/0001493152-22-024444-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000149315222024444/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-024444

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer